Dermatology News

The cosmetic industry is preparing for yet another rapidly approaching deadline imposed by the Modernization of Cosmetics Registration Act of 2022.

The FDA has granted rare pediatric disease designation to Descartes-08, an autologous mRNA cell therapy, for the treatment of juvenile dermatomyositis, Cartesian Therapeutics announced in a press release.

One important investment vehicle to understand when working toward slow and steady growth is the index fund.

A low dose of interleukin-2 therapy showed positive results in the treatment of bullous pemphigoid with an early onset of response, according to a study.

Fish oil supplementation during pregnancy was associated with children having a lower or higher risk for developing atopic dermatitis depending on the mother’s genotype, according to a study.

Quitting smoking and maintaining smoking cessation was associated with a reduced risk for developing hidradenitis suppurativa, according to a study.

The DecisionDx-SCC test successfully identified which patients with cutaneous squamous cell carcinoma would most likely benefit from adjuvant radiation therapy, according to a study.

Biosimilar medications — drugs developed to be very similar, but not identical, to an FDA-approved biologic — were intended to play a vital role in increasing affordable options for patients struggling with a range of chronic conditions.

The COVID-19 pandemic had a great impact on the health care system and the well-being of health care professionals, the effects of which are still felt today.

The FDA has not approved a new sunscreen ingredient since the 1990s, leaving consumers and clinicians wondering why.